Modulus Discovery, Inc., is a preclinical-stage technology-driven drug discovery firm with offices in Tokyo and Boston. The company is pursuing its portfolio of small-molecule discovery programs and collaborations through integration of its unique core biology insights, cutting-edge simulation platform, and scalable networked operations. Modulus is focused on the efficient delivery of breakthrough medicines for patients and their families with unmet medical needs in areas including oncology, chronic inflammation / immune disorders, infectious diseases, and rare genetic conditions.
View Top Employees from Modulus DiscoveryWebsite | http://www.modulusdiscovery.com |
Revenue | $5 million |
Funding | $32.7 million |
Employees | 5 (5 on RocketReach) |
Founded | 2016 |
Address | 1 Broadway, Fl 14, Cambridge, Massachusetts 02142, US |
Industry | Biotechnology, Drug Manufacturing & Research, Drug Discovery, Pharmaceuticals, Science and Engineering, Healthcare, Clinical Trials, Health Care, Pharmaceutical |
SIC | SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Modulus Discovery employee's phone or email?
The Modulus Discovery annual revenue was $5 million in 2024.
Michael Kuran is the Head, Business Development, Licensing and Partnering of Modulus Discovery.
5 people are employed at Modulus Discovery.
Modulus Discovery is based in Cambridge, Massachusetts.
The NAICS codes for Modulus Discovery are [325, 3254, 32].
The SIC codes for Modulus Discovery are [80, 283, 28].